Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity

PURPOSE: We tested the efficacy and toxicity of cisplatin plus accelerated fractionation with a concomitant boost (AFX-C) versus standard fractionation (SFX) in locally advanced head and neck carcinoma (LA-HNC). PATIENTS AND METHODS: Patients had stage III to IV carcinoma of the oral cavity, orophar...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Oncol
Autori principali: Nguyen-Tan, Phuc Felix, Zhang, Qiang, Ang, K. Kian, Weber, Randal S., Rosenthal, David I., Soulieres, Denis, Kim, Harold, Silverman, Craig, Raben, Adam, Galloway, Thomas J., Fortin, André, Gore, Elizabeth, Westra, William H., Chung, Christine H., Jordan, Richard C., Gillison, Maura L., List, Marcie, Le, Quynh-Thu
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Clinical Oncology 2014
Soggetti:
ORIGINAL REPORTS
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4239304/
https://ncbi.nlm.nih.gov/pubmed/25366680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.55.3925
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi